Author = Shaygannejad, Vahid
Study of The Correlation between miR-106a, miR-125b, and miR-330 on Multiple Sclerosis Patients by Targeting TNFSF4 and SP1 in NF-кb/TNF-α Pathway: A Case-Control Study

Volume 24, Issue 7, July 2022, Pages 403-409

10.22074/cellj.2022.7835

Nasrin Hadi; Seyed Morteza Seifati; Behnaz Nateghi; Parisa Ravaghi; Farinaz Khosravian; Faezeh Namazi; Maryam Fotouhi Firouzabad; Vahid Shaygannejad; Mansoor Salehi


Comparison of The Expression of miR-326 between Interferon beta Responders and Non-Responders in Relapsing-Remitting Multiple Sclerosis

Volume 22, Issue 1, September 2019, Pages 92-95

10.22074/cellj.2020.6486

Mahtab Fattahi; Nahid Eskandari; Fattah Sotoodehnejadnematalahi; Vahid Shaygannejad; Kazemi Mohammad


OX40 Gene and Serum Protein Expression Profiles in Patients with Parkinson’s Disease

Volume 20, Issue 2, January 2018, Pages 177-182

10.22074/cellj.2018.5038

Azadeh Seyedjoodaki; Fereshteh Alsahebfosoul; Nahid Eskandari; Vahid Shaygannejad; Mansour Salehi; Mohammad Kazemi; Mostafa Manian; Omid Mirmosayyeb; Mohammad Taghi Kardi